{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:51:25Z","timestamp":1790693485741,"version":"4.1.0"},"reference-count":574,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neubiorev.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T01:45:36Z","timestamp":1555292736000},"page":"56-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"special_numbering":"C","title":["Depression in neurodegenerative diseases: Common mechanisms and current treatment options"],"prefix":"10.1016","volume":"102","author":[{"given":"Ciaran P.C.","family":"Galts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.B.","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Brocardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lucia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gil-Mohapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2019.04.002_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u2014epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0010","doi-asserted-by":"crossref","first-page":"e012759","DOI":"10.1136\/bmjopen-2016-012759","article-title":"Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series","volume":"7","author":"Abraha","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0015","first-page":"478","article-title":"Dysthymia in neurological disorders","volume":"1","author":"Akiskal","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer's Association","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer's Association","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-160225","article-title":"The effect of escitalopram on mood and cognition in depressive Alzheimer's disease subjects","volume":"55","author":"An","year":"2016","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pscychresns.2008.03.012","article-title":"Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression","volume":"171","author":"Anand","year":"2009","journal-title":"Psychiatry Res. \u2013 Neuroimaging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0040","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","article-title":"Gut permeability and microbiota in Parkinson's disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S003329179700593X","article-title":"Puberty and depression: the roles of age, pubertal status and pubertal timing","volume":"28","author":"Angold","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.nut.2014.03.024","article-title":"Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice","volume":"30","author":"Antunes","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0055","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neuropsychologia.2007.10.026","article-title":"Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment","volume":"46","author":"Apostolova","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner","volume":"122","author":"Arning","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease","volume":"42","author":"Augood","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00415-005-0835-7","article-title":"Gender and the Parkinson's disease phenotype","volume":"252","author":"Baba","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0075","series-title":"Cochrane Database of Systematic Reviews","first-page":"CD003944","article-title":"Antidepressants for treating depression in dementia","author":"Bains","year":"2002"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107691","article-title":"Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of huntington disease","volume":"9","author":"Baldo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/nn.4112","article-title":"Sex differences and stress across the lifespan","author":"Bale","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-0327(00)00375-X","article-title":"A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies","author":"Ballard","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2008.03.023","article-title":"Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments","volume":"1211","author":"Balu","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.euroneuro.2008.11.005","article-title":"Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress","volume":"19","author":"Bambico","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17070","article-title":"Study of the use of antidepressants for depression in dementia: the HTA-SADD trial\u2014a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","volume":"17","author":"Banerjee","year":"2013","journal-title":"Health Technol. Assess. (Rockv)."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pnpbp.2014.02.009","article-title":"PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease","volume":"53","author":"Barbiero","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.62.6.685","article-title":"Sex differences in the clinical manifestations of Alzheimer disease pathology","author":"Barnes","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0120","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","article-title":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats","volume":"1593","author":"Bassani","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N. Engl. J. Med. Downloaded"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0140","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.5110-12.2013","article-title":"Huntingtin mediates anxiety\/depression-related behaviors and hippocampal neurogenesis","volume":"33","author":"Ben M\u2019Barek","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2013.10.005","article-title":"Stress and trauma: BDNF control of dendritic-spine formation and regression","author":"Bennett","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0150","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1523\/JNEUROSCI.21-17-06718.2001","article-title":"Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain","volume":"21","author":"Benraiss","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117698","article-title":"Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of parkinson's disease: an influence of chronic pramipexole in rats","volume":"10","author":"Berghauzen-Maciejewska","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11302-016-9509-4","article-title":"Guanosine and its role in neuropathologies","volume":"12","author":"Bettio","year":"2016","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.brs.2016.12.014","article-title":"The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease","volume":"10","author":"Birchall","year":"2017","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0185","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0190","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington disease","volume":"54","author":"Bohnen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0195","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2017.11.009","article-title":"Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats","volume":"300","author":"Bonato","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14656566.5.4.767","article-title":"A review of the treatment options for Huntington's disease","volume":"5","author":"Bonelli","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0210","doi-asserted-by":"crossref","unstructured":"Borgonovo, J., Allende-Castro, C., Laliena, A., Guerrero, N., Silva, H., Concha, M.L., Guerrero, E., An Silva, H., Concha, M.L., 2017. Changes in neural circuitry associated with depression at preclinical, pre-motor and early motor phases of Parkinson's disease. 35, 17\u201324. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.009.","DOI":"10.1016\/j.parkreldis.2016.11.009"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","article-title":"BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis","volume":"76","author":"Bramham","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuroscience.2010.04.023","article-title":"Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats","volume":"168","author":"Brummelte","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0235","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biopsych.2005.09.022","article-title":"BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects","volume":"59","author":"Bueller","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik-sullivan","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0245","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(69)91921-7","article-title":"Effect of L-DOPA on depression","volume":"2","author":"Bunney","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1533317508317527","article-title":"The effects of a multimodal intervention on outcomes of persons with early-stage dementia","volume":"23","author":"Burgener","year":"2008","journal-title":"Am. J. Alzheimer's Dis. Other Demen."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2005.11.005","article-title":"Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease","volume":"12","author":"Burn","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0260","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer's disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/S1364-6613(00)01483-2","article-title":"Cognitive and emotional influences in anterior cingulate cortex","author":"Bush","year":"2000","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2009.05.014","article-title":"Neuronal plasticity: a link between stress and mood disorders","author":"Calabrese","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)64064-3","article-title":"Augmented senile plaque load in aged female \u03b2-amyloid precursor protein-transgenic mice","author":"Callahan","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0280","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","article-title":"Effects of gender on nigral gene expression and parkinson disease","volume":"26","author":"Cantuti-Castelvetri","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0285","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng1395","article-title":"VEGF links hippocampal activity with neurogenesis, learning and memory","volume":"36","author":"Cao","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.40.6.581","article-title":"Biochemical aspects of Huntington's chorea","volume":"40","author":"Caraceni","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer's disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0300","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1523\/JNEUROSCI.3836-11.2011","article-title":"Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy","volume":"31","author":"Carroll","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2010.10.009","article-title":"Sex differences in \u03b2-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure","author":"Carroll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity","volume":"70","author":"Castr\u00e9n","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","article-title":"Role of neurotrophic factors in depression","volume":"7","author":"Castr\u00e9n","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0320","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory (MPTP) rat model of Parkinson\u2019 s disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0325","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0006-8993(97)01566-7","article-title":"5-HT1B receptor binding in degenerative movement disorders","volume":"790","author":"Castro","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0330","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human \u03b1-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0335","volume":"18","author":"Cauwenberghe","year":"2016","journal-title":"Open the genetic landscape of Alzheimer disease: clinical implications and perspectives"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington's disease","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychires.2017.02.010","article-title":"Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings","volume":"90","author":"Chagas","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0350","first-page":"438","article-title":"Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy","volume":"60","author":"Chan-Palay","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0360","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000125250","article-title":"Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain","volume":"50","author":"Chao","year":"1989","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/01674820109049960","article-title":"Predictors, prodromes and incidence of postpartum depression","volume":"22","author":"Chaudron","year":"2001","journal-title":"J. Psychosom. Obstet. Gynecol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0375","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2990.2000.00254.x","article-title":"Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes","volume":"26","author":"Chen","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0380","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-2011-110002","article-title":"Disturbed neurotransmitter transporter expression in Alzheimer's disease brain","volume":"26","author":"Chen","year":"2011","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0385","article-title":"ER \u03b2 and ApoE isoforms interact to regulate BDNF\u20135-HT 2A signaling and synaptic function in the female brain","volume":"1\u201310","author":"Chhibber","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0390","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-140324","article-title":"Depression in Alzheimer's disease: epidemiology, mechanisms, and management","volume":"42","author":"Chi","year":"2014","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0395","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0400","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2015.03.020","article-title":"Long-term treatment with l-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease","volume":"95","author":"Chiu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0405","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2015.05.010","article-title":"Progression of behavioural despair in R6\/2 and Hdh knock-in mouse models recapitulates depression in Huntington's disease","volume":"291","author":"Ciamei","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0410","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.physbeh.2014.04.021","article-title":"Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1-42) rat model of Alzheimer's disease","volume":"131","author":"Cioanca","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10072-011-0618-0","article-title":"Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study","volume":"33","author":"Clerici","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2007.06.013","article-title":"Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice","author":"Clinton","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/gte.2004.8.114","article-title":"Prevalence of major depression one year after predictive testing for Huntington's disease","volume":"8","author":"Codori","year":"2004","journal-title":"Genet. Test."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1532-5415.1993.tb06697.x","article-title":"Sex differences in the psychiatric manifestations of Alzheimer's disease","volume":"41","author":"Cohen","year":"1993","journal-title":"J. Am. Geriatr. Soc"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0440","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0445","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-2236(02)02143-4","article-title":"Exercise: a behavioral intervention to enhance brain health and plasticity","author":"Cotman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0455","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-510X(83)90149-1","article-title":"Monoamine metabolism in senile dementia of Alzheimer type","volume":"60","author":"Cross","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2015.11.003","article-title":"Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: a European population study","volume":"80","author":"Dale","year":"2016","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0465","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine \u2013 searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0470","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11606-014-2916-8","article-title":"Neuropsychiatric disorders and potentially preventable hospitalizations in a prospective cohort study of older Americans","volume":"29","author":"Davydow","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0475","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer's disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4056383","article-title":"Antidepressant effects of probucol on early-symptomatic YAC128 transgenic mice for Huntington's disease","volume":"2018","author":"de Paula Nascimento-Castro","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002826-199702000-00003","article-title":"The management of coexisting depression in patients with dementia: potential of calcium channel antagonists","volume":"20","author":"De Vry","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0490","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jnc.13253","article-title":"Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease","volume":"135","author":"Deusser","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0495","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0500","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.116.532.255","article-title":"Socio-psychiatric consequences of Huntington's disease","volume":"116","author":"Dewhurst","year":"1970","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0505","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0510","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hipo.450020409","article-title":"Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation","volume":"2","author":"Diamond","year":"1992","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0515","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1749-6632.1994.tb39271.x","article-title":"Stress impairs LTP and hippocampal-dependent memory","volume":"746","author":"Diamond","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0520","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0525","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0530","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.22134","article-title":"Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease","volume":"24","author":"Dissanayaka","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0535","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-\u03b1 and IL-6 with ageing and parkinsonism","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0540","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mds.21455","article-title":"Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study","volume":"22","author":"Dobkin","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0545","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-2011-111328","article-title":"Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease","volume":"28","author":"Dong","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0550","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0555","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, Spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21-40) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0560","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0565","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1092852900013754","article-title":"The subgenual anterior cingulate cortex in mood disorders","volume":"13","author":"Drevets","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0570","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/tp.2012.58","article-title":"Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease","volume":"2","author":"Du","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0575","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00032","article-title":"Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?","author":"Du","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0580","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2014.09.009","article-title":"The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease","volume":"263","author":"Du","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0585","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2013.00081","article-title":"A tale of two maladies? Pathogenesis of depression with and without the Huntington's disease gene mutation","author":"Du","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0590","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0595","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0600","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/da.22227","article-title":"Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections","author":"Duman","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0605","series-title":"Synaptic Plasticity and Mood Disorders","author":"Duman","year":"2002"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0610","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0615","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0620","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","article-title":"A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists","volume":"367","author":"Duman","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0625","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","author":"Duman","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0630","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0635","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0893-133X(01)00358-X","article-title":"Regulation of adult neurogenesis by antidepressant treatment","volume":"25","author":"Duman","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0640","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0645","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington's disease: a decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0650","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jpsychires.2013.05.026","article-title":"Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study","volume":"47","author":"Epping","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0655","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/nmt.11.45","article-title":"Depression in the early stages of Huntington disease: beyond motor symptoms","volume":"1","author":"Epping","year":"2011","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0660","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1073858410397054","article-title":"The aging hippocampus: interactions between exercise, depression, and BDNF","volume":"18","author":"Erickson","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0665","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of L-DOPA treatment Bishopa","volume":"35","author":"Eskow Juanarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0670","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/mds.23806","article-title":"Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease","volume":"26","author":"Factor","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0675","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuroscience.2003.09.029","article-title":"Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male sprague-dawley rats in vivo","volume":"124","author":"Farmer","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota\u2013gut\u2013brain signalling in Parkinson's disease: implications for non-motor symptoms","author":"Felice","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0690","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(87)91506-X","article-title":"Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum","volume":"416","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0695","doi-asserted-by":"crossref","DOI":"10.1159\/000327754","article-title":"Suicidal behavior in prodromal Huntington disease","author":"Fiedorowicz","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0700","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1601-183X.2008.00453.x","article-title":"Cognitive and non-cognitive behaviors in an APPswe\/PS1 bigenic model of Alzheimer's disease","volume":"8","author":"Filali","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0705","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0896-6273(00)80866-1","article-title":"CREB couples neurotrophin signals to survival messages","volume":"25","author":"Finkbeiner","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0710","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hbm.20426","article-title":"A meta-analytic study of changes in brain activation in depression","volume":"29","author":"Fitzgerald","year":"2008","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0715","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","article-title":"Review the genetics of major depression","volume":"81","author":"Flint","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0720","doi-asserted-by":"crossref","DOI":"10.3758\/CABN.8.4.375","article-title":"Cortico\u2013limbic\u2013striatal circuits subserving different forms of cost-benefit decision making","author":"Floresco","year":"2008","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0725","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S0033291700047966","article-title":"The association of affective disorder with Huntington's disease in a case series and in families","volume":"13","author":"Folstein","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0730","series-title":"The Genetic Basis of Parkinson\u2019 s Disease","first-page":"363","author":"Foltynie","year":"2002"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0735","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.psyneuen.2015.10.019","article-title":"MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice","volume":"63","author":"Fonken","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0740","article-title":"Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington's disease mice","author":"Fons\u00eaca","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0745","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","article-title":"Differences in duration of Huntington's disease based on age at onset","volume":"66","author":"Foroud","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0750","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.61.1.62","article-title":"Hormones and menopausal status as predictors of depression in women in transition to menopause","author":"Freeman","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0755","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/jnnp.2003.027060","article-title":"Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease","volume":"75","author":"Fregni","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0760","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720509788486527","article-title":"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease","volume":"6","author":"Freude","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0765","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1474-4422(16)30040-0","article-title":"Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?","volume":"15","author":"Frisoni","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0770","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4306\/pi.2010.7.4.251","article-title":"Epigenetic regulation of BDNF gene in response to stress","volume":"7","author":"Fuchikami","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0775","doi-asserted-by":"crossref","DOI":"10.1016\/S1734-1140(13)71527-5","article-title":"Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems","author":"Gadek-Michalska","year":"2013","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0780","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0785","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.celrep.2015.07.005","article-title":"Depression of serotonin synaptic transmission by the dopamine precursor L-DOPA","volume":"12","author":"Gantz","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0790","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2018.07.007","article-title":"Depressive- and anxiety-like phenotypes in young adult APPSwe\/PS1dE9 transgenic mice with insensitivity to chronic mild stress","volume":"353","author":"Gao","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0795","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","article-title":"Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease","volume":"27","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0800","doi-asserted-by":"crossref","DOI":"10.1038\/srep31652","article-title":"Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease","volume":"6","author":"Garcia-Miralles","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0805","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2016.01.019","article-title":"Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease","volume":"278","author":"Garcia-Miralles","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0810","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00002826-200001000-00009","article-title":"Bradykinesia in Huntington's disease","volume":"23","author":"Garcia Ruiz","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0815","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0820","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0825","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.01.016","article-title":"Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity","author":"Gerhard","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0835","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0024-3205(80)90368-9","article-title":"Motor effects of serotonin in the central nervous system","volume":"27","author":"Gerson","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0840","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2014.06.011","article-title":"YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease","volume":"1581","author":"Ghilan","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0845","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0850","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0855","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3233\/JAD-2010-100663","article-title":"HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease","volume":"22","author":"Gil-Bea","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0860","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","article-title":"The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?","volume":"15","author":"Gil-Mohapel","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0865","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2011.06.040","article-title":"Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies?","volume":"1406","author":"Gil-Mohapel","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0870","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington's disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0875","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0880","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease, braini0307","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0885","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0890","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","article-title":"Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine","volume":"256","author":"Goes","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0895","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.pmbts.2015.07.002","article-title":"Exercise and regulation of adipokine and myokine production","volume":"135","author":"G\u00f6rgens","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0900","first-page":"433","article-title":"Cholinesterase inhibitors and behavioral and psychological symptoms of Alzheimer's disease","volume":"99","author":"Graipaspong","year":"2016","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0905","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE Study","volume":"60","author":"Green","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0910","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0915","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0920","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2008.05.008","article-title":"Genetic risk factors and markers for Alzheimer's disease and\/or depression in the VITA study","volume":"43","author":"Grunblatt","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0925","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","article-title":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","volume":"353","author":"Guerra de Souza","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0930","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12888-015-0691-7","article-title":"Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer's disease patients with depression: a 1H magnetic resonance spectroscopy study","volume":"15","author":"Guo","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0935","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson disease: a nationwide cohort study","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0940","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0945","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Guttmacher","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0950","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.315","article-title":"L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor\/PKA signaling pathway","volume":"6","author":"Hao","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0955","first-page":"79","article-title":"New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease","volume":"60","author":"Harada","year":"2011","journal-title":"Hiroshima J. Med. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0960","series-title":"Reconstructive Neurosurgery","first-page":"89","article-title":"Transgenic rodent models of Parkinson's disease","author":"Harvey","year":"2008"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0965","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0970","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/mp.2013.108","article-title":"Stress exacerbates experimental Parkinson's disease","volume":"19","author":"Hemmerle","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0975","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2011.09.035","volume":"233","author":"Hemmerle","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0980","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1176\/appi.ajp.161.6.1096","article-title":"Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression","volume":"161","author":"Hendricksen","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0985","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yfrne.2015.12.001","article-title":"Depression as a risk factor for Alzheimer's disease: genes, steroids, cytokines and neurogenesis \u2013 what do we need to know?","volume":"41","author":"Herbert","year":"2016","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0990","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/mend-3-11-1886","article-title":"Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat","volume":"3","author":"Herman","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib0995","series-title":"Handbook of Depression in Adolescents","first-page":"111","article-title":"The emergence of gender differences in depression in adolescence","author":"Hilt","year":"2009"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1000","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mds.22412","article-title":"Health-related quality of life in Huntington's disease: which factors matter most?","volume":"24","author":"Ho","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YIC.0b013e3283348018","article-title":"Combating depression in Huntington\u02bcs disease: effective antidepressive treatment with venlafaxine XR","volume":"25","author":"Holl","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archpsyc.56.1.45","article-title":"Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease","volume":"56","author":"Hoogendijk","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2005.07.017","article-title":"Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression","volume":"27","author":"Hoogendijk","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1020","doi-asserted-by":"crossref","DOI":"10.1186\/s12993-015-0059-7","article-title":"Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer's disease","volume":"11","author":"Hritcu","year":"2015","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jad.2013.06.001","article-title":"Suicidal ideation in a European Huntington's disease population","volume":"151","author":"Hubers","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jne.12255","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis functioning in Huntington\u2019 s disease and its association with depressive symptoms and suicidality neuroendocrinology","volume":"27","author":"Hubers","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jad.2011.10.031","article-title":"Suicidality in Huntington's disease","volume":"136","author":"Hubers","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1040","article-title":"A25 Psychiatric and metabolic changes in the BACHD mouse model of Huntington's disease","volume":"81","author":"Hult","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1045","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of huntington's disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/brain\/awl332","article-title":"The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea","volume":"130","author":"Huot","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","article-title":"BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra","volume":"350","author":"Hyman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exnr.2000.7415","article-title":"Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain","volume":"164","author":"Ickes","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","article-title":"A systematic review of depression and mental illness preceding Parkinson's disease","volume":"113","author":"Ishihara","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1070","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1523\/JNEUROSCI.6394-10.2011","article-title":"Estrogen shapes dopamine-dependent cognitive processes: implications for women's health","volume":"31","author":"Jacobs","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.neubiorev.2019.04.002_bib1080","first-page":"277S","article-title":"Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease","volume":"15","author":"Jenner","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1192\/bjp.163.6.790","article-title":"A study of psychiatric morbidity in patients with Huntington's disease, their relatives, and controls. Admissions to psychiatric hospitals in Denmark from 1969 to 1991","volume":"163","author":"Jensen","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0303-8467(80)90017-7","article-title":"Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic\u2014rigid form","volume":"82","author":"Jongen","year":"1980","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1095","series-title":"Stress and HPA Axis Dysfunction in Alzheimer's Disease","first-page":"159","author":"Joshi","year":"2013"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","article-title":"Psychiatric disorders in preclinical Huntington's disease","volume":"78","author":"Julien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1105","doi-asserted-by":"crossref","first-page":"219427","DOI":"10.5402\/2011\/219427","article-title":"Apathy and anhedonia in Parkinson's disease","volume":"2011","author":"Kaji","year":"2011","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1110","doi-asserted-by":"crossref","first-page":"e51197","DOI":"10.1371\/journal.pone.0051197","article-title":"Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic\/growth factors: differential regulation of FGF-2 by noradrenaline","volume":"7","author":"Kajitani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1115","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.273.5280.1402","article-title":"A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity","volume":"273","author":"Kang","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-\u03b1 in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1125","first-page":"108","article-title":"Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length","volume":"36","author":"Kehoe","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.annepidem.2016.02.008","article-title":"Brain\u2013gut\u2013microbiota axis: challenges for translation in psychiatry","volume":"26","author":"Kelly","year":"2016","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/386493a0","article-title":"More hippocampal neurons in adult mice living in an enriched environment","volume":"386","author":"Kempermann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(93)90026-G","article-title":"Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence","volume":"29","author":"Kessler","year":"1993","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-148003","article-title":"Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments","volume":"44","author":"Khundakar","year":"2015","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.mehy.2008.06.036","article-title":"Impact of glucocorticoids and chronic stress on progression of Parkinson's disease","volume":"71","author":"Kibel","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1037\/neu0000199","article-title":"Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease","volume":"29","author":"Kim","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn849","article-title":"The stressed hippocampus, synaptic plasticity and lost memories","volume":"3","author":"Kim","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4306\/pi.2010.7.2.135","article-title":"Apolipoprotein E4 genotype and depressive symptoms as risk factors for dementia in an older Korean population","volume":"7","author":"Kim","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1479-8301.2009.00293.x","article-title":"Serum amyloid \u03b2 protein in young and elderly depression: a pilot study","volume":"9","author":"Kita","year":"2009","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1175","first-page":"1135","volume":"vol. 115","author":"Kitamura","year":"2013"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1180","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.pharep.2017.05.016","article-title":"Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle","volume":"69","author":"Konieczny","year":"2017","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1185","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","article-title":"Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"30","author":"Koolschijn","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00314109","article-title":"Depression and parkinson's disease: possible role of serotonergic mechanisms","volume":"234","author":"Kosti\u0107","year":"1987","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1503\/jpn.100067","article-title":"Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography","volume":"36","author":"Krogias","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10863-012-9479-3","article-title":"A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers","volume":"45","author":"Krzyszto\u0144-Russjan","year":"2013","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1210","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0447.2003.00204.x","article-title":"Gender differences in unipolar depression: an update of epidemiological findings and possible explanations","author":"Kuehner","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1215","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/BF01271258","article-title":"Depression in Parkinson's disease: biogenic amines in CSF of \u201cde novo\u201d patients","volume":"103","author":"Kuhn","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJPR\/2016\/28054","article-title":"A review on Huntington's disease","volume":"13","author":"Kumar","year":"2016","journal-title":"Br. J. Pharm. Res. Aust."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer's disease pathophysiology and its management: an update","author":"Kumar","year":"2015","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0006-3223(02)01369-0","article-title":"Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects","volume":"52","author":"Laakso","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02252964","article-title":"Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions","volume":"9","author":"Laakso","year":"1995","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1240","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jad.2011.06.022","article-title":"The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials","volume":"136","author":"Lai","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1245","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.57.8.787","article-title":"Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness","volume":"57","author":"Lambert","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2016.05.057","article-title":"Exploring the excess mortality due to depressive symptoms in a community-based sample: the role of Alzheimer's Disease","volume":"202","author":"Lara","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10897-006-9027-6","article-title":"Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study","volume":"15","author":"Larsson","year":"2006","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1260","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","article-title":"Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1265","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer's amyloid- oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1270","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1275","article-title":"Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1280","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1095760","article-title":"Independent Cellular processes for hippocampal memory consolidation and reconsolidation","volume":"304","author":"Lee","year":"2004","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1285","series-title":"Parkinson disease: depression\u2014risk factor or early symptom in Parkinson disease?","author":"Leentjens","year":"2015"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11585380-000000000-00000","article-title":"The role of dopamine agonists in the treatment of depression in patients with Parkinson\u02bcs disease","volume":"71","author":"Leentjens","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1295","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","article-title":"Inflammation, depression and dementia: are they connected?","volume":"32","author":"Leonard","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1300","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1523\/JNEUROSCI.20-23-08604.2000","article-title":"Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory","volume":"20","author":"Leranth","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1305","doi-asserted-by":"crossref","first-page":"24438","DOI":"10.3390\/ijms141224438","article-title":"Oxidative stress and neurodegenerative disorders","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1315","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2014.01.002","article-title":"Sex differences in cognitive impairment and Alzheimer's disease","author":"Li","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psyneuen.2014.01.006","article-title":"Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults","volume":"42","author":"Lin","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1330","doi-asserted-by":"crossref","first-page":"e47387","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson's disease\u2014correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1335","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2015.03.031","article-title":"Serotonin receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats","volume":"95","author":"Liu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1340","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4088\/JCP.13m08564","article-title":"Depressive symptoms in healthy apolipoprotein E \u03b54 carriers and noncarriers: a longitudinal study","volume":"74","author":"Locke","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1345","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1350","series-title":"Association of Existing and New Candidate Genes for Anxiety, Depression and Personality Traits in Older People","first-page":"518","author":"Luciano","year":"2010"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1355","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1007\/s12035-016-0134-6","article-title":"Atorvastatin protects from A\u03b21-40-induced cell damage and depressive-like behavior via ProBDNF cleavage","volume":"54","author":"Ludka","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson's disease","author":"Lunati","year":"2018","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1365","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/jnnp-2013-306237","article-title":"Resting-state fMRI study on drug-naive patients with Parkinson\u2019s disease and with depression","volume":"85","author":"Luo","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1370","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainresbull.2014.11.006","article-title":"Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson's disease","volume":"110","author":"Luo","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1375","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2639","article-title":"Effects of stress throughout the lifespan on the brain, behaviour and cognition","author":"Lupien","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1380","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-3223(02)01348-3","article-title":"Depression in Alzheimer's disease: overview and treatment","author":"Lyketsos","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1385","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's-disease chromosomes","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1390","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2010.80","article-title":"The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research","volume":"16","author":"MacQueen","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1395","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2013.11.009","article-title":"Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects","author":"Mahar","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1400","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u00e9s disease","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1405","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.amepre.2013.08.001","article-title":"Physical activity and the prevention of depression","volume":"45","author":"Mammen","year":"2013","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1410","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1415","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/WNL.54.4.833","article-title":"Endogenous estrogen levels and Alzheimer's disease among postmenopausal women","volume":"54","author":"Manly","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1420","first-page":"2","article-title":"Psychiatric symptoms of basal ganglia disorders: evaluation and management","volume":"12","author":"Marchand","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1425","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1430","doi-asserted-by":"crossref","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","author":"Martinowich","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1435","first-page":"139","article-title":"Screening for depression","volume":"85","author":"Maurer","year":"2012","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1440","doi-asserted-by":"crossref","DOI":"10.1093\/bmb\/65.1.193","article-title":"Modulating dysfunctional limbic\u2013cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment","author":"Mayberg","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1445","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.42.9.1791","article-title":"Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease","volume":"42","author":"Mayberg","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1450","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with parkinson's disease","volume":"34","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1455","first-page":"363","volume":"54","author":"Mcdonald","year":"2003","journal-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1460","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2016.12.021","article-title":"Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice","volume":"116","author":"McGregor","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1465","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<85::AID-SYN1>3.0.CO;2-Y","article-title":"Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites","volume":"36","author":"McKittrick","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009793","article-title":"Comprehensive behavioral testing in the R6\/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline","volume":"5","author":"Menalled","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/089198879901200202","article-title":"Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter","volume":"12","author":"Menza","year":"1999","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1485","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1490","doi-asserted-by":"crossref","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1495","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/ajp.152.1.37","article-title":"Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease","volume":"152","author":"Migliorelli","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S146114571000043X","article-title":"Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease","volume":"14","author":"Miguelez","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1505","doi-asserted-by":"crossref","DOI":"10.1002\/mds.23388","article-title":"Gender differences in Parkinson's disease: clinical characteristics and cognition","author":"Miller","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1510","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1515","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/jnnp.48.11.1172","article-title":"A comparison of the frequency of major affective disorder in Huntington's disease and Alzheimer's disease","volume":"48","author":"Mindham","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1520","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2014.05.004","article-title":"High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice","volume":"69","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1525","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2014.07.008","article-title":"Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice","volume":"71","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1530","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-2010-100153","article-title":"Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment","volume":"21","author":"Modrego","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1535","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1540","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.62.2.188","article-title":"Free testosterone and risk for Alzheimer disease in older men","volume":"62","author":"Moffat","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1545","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1550","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","article-title":"Serum levels of brain-derived neurotrophic factor in major depressive disorder: state\u2013trait issues, clinical features and pharmacological treatment","volume":"16","author":"Molendijk","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1555","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1560","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.parkreldis.2014.02.025","article-title":"Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease","volume":"20","author":"Moonen","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1565","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"Morais","year":"2012","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1570","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","article-title":"Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease","volume":"117","author":"Moreira","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1575","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","article-title":"Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-methyl-4-phenylpyridinium (MPP+)","volume":"28","author":"Moretti","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1580","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.phrs.2017.11.034","article-title":"N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype","volume":"129","author":"Morgese","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1585","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2174\/13816128113199990500","article-title":"Modulatory activity of soluble beta amyloid on HPA axis function in rats","volume":"20","author":"Morgese","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1590","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-0102(96)01105-4","article-title":"Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study","volume":"26","author":"Morimoto","year":"1996","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1595","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000849","article-title":"Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease","volume":"6","author":"M\u00f6ssner","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1600","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.25980","article-title":"Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease","volume":"29","author":"Moulton","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1750-1326-6-85","article-title":"Adult hippocampal neurogenesis and its role in Alzheimer's disease","volume":"6","author":"Mu","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1610","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000064926","article-title":"Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men","volume":"14","author":"M\u00fcller-Thomsen","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1615","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1620","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.01.014","article-title":"Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice","volume":"583","author":"Murray","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1625","article-title":"Changes in cytokines and neurotrophins in Parkinson's disease","volume":"Suppl. 277\u201390","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1630","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00711237","article-title":"Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study","volume":"12","author":"Nazarali","year":"1992","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1635","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2016.10.004","article-title":"Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice","volume":"150\u2013151","author":"Neis","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1640","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1532-5415.2011.03355.x","article-title":"A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia","volume":"59","author":"Nelson","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1645","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1650","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1655","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0447.2002.02229.x","article-title":"Major depressive disorder in Parkinson's disease: a register-based study","volume":"106","author":"Nilsson","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1660","doi-asserted-by":"crossref","DOI":"10.1177\/0269215510376004","article-title":"Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial","author":"Niu","year":"2010","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1665","doi-asserted-by":"crossref","DOI":"10.1037\/0033-2909.115.3.424","article-title":"The emergence of gender differences in depression during adolescence","author":"Nolen-Hoeksema","year":"1994","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1670","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02784278","article-title":"Alterations in serum and brain trace element levels after antidepressant treatment","volume":"67","author":"Nowak","year":"1999","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1675","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0006-3223(00)00944-6","article-title":"Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology","volume":"49","author":"O\u2019Brien","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1680","first-page":"1","volume":"vol. 6","author":"Oertel","year":"2017"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1685","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2015.09.005","article-title":"New insight into the therapeutic role of the serotonergic system in Parkinson's disease","volume":"134","author":"Ohno","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1690","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/meta.2000.9515","article-title":"Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis","volume":"49","author":"Okamura","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1695","doi-asserted-by":"crossref","first-page":"e101763","DOI":"10.1371\/journal.pone.0101763","article-title":"Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart","volume":"9","author":"Olivola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1700","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1705","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1710","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","article-title":"Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction","volume":"28","author":"Origlia","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1715","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1720","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1725","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.410260103","article-title":"A quantitative investigation of the substantia nigra in Huntington's disease","volume":"26","author":"Oyanagi","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1730","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","article-title":"Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease","volume":"68","author":"Pahwa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1735","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/mds.23270","article-title":"The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study","volume":"25","author":"Pal","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1740","doi-asserted-by":"crossref","DOI":"10.1093\/bmb\/lds004","article-title":"The neurobiology of depression","author":"Palazidou","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1745","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.yfrne.2014.03.002","article-title":"Development of the HPA axis: where and when do sex differences manifest?","volume":"35","author":"Panagiotakopoulos","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1750","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington's disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1755","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum?","volume":"18","author":"Panza","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1760","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.arr.2011.06.005","article-title":"Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease","volume":"11","author":"Panza","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1765","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q","article-title":"The selective vulnerability of brainstem nuclei to Alzheimer's disease","volume":"49","author":"Parvizi","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00162","article-title":"Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice","volume":"6","author":"Patel","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1775","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2013.08.003","article-title":"A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases","author":"Paulsen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1780","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/jnp.17.4.496","article-title":"Depression and stages of Huntington's disease","volume":"17","author":"Paulsen","year":"2005","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1785","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10654-007-9157-7","article-title":"Survival of Huntington's disease patients in Serbia: longer survival in female patients","volume":"22","author":"Pekmezovic","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1790","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1795","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000356531","article-title":"Depression and cognitive impairment in Parkinson's disease: a role for inflammation and immunomodulation?","volume":"21","author":"Pessoa Rocha","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1800","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Peters\u00e9n","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1805","article-title":"Major depressive symptoms increase 3-year mortality rate in patients with mild dementia","volume":"2017","author":"Petersen","year":"2017","journal-title":"Int. J. Alzheimers. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1810","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson's disease: a systematic review and meta-analysis","volume":"21","author":"Pfeiffer","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1815","first-page":"25","article-title":"Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial","volume":"31","author":"Picelli","year":"2016","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1820","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1825","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1830","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson's disease","volume":"277","author":"Politis","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1835","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn3138","article-title":"The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission","volume":"13","author":"Popoli","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1840","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1845","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1850","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1855","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders","author":"Price","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1860","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","author":"Prince","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1865","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1870","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2010.06.011","article-title":"Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia","volume":"33","author":"Proitsi","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1875","article-title":"The randomized controlled trial of pramipexole treatment of Parkinson's disease and depression","author":"Qian","year":"2011","journal-title":"Prog. Mod. Biomed."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1880","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.1710","article-title":"Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly","volume":"22","author":"Qiu","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1885","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cld.614","article-title":"What can we learn from other clinical settings on the influence of the gut microbiome on the brain?","volume":"9","author":"Quigley","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1890","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression","volume":"63","author":"Rapp","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1895","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JGP.0b013e31816029ec","article-title":"Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression","volume":"16","author":"Rapp","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1900","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/01.wnl.0000341932.21961.f3","article-title":"Increased striatal dopamine (D2\/D3) receptor availability and delusions in Alzheimer disease","volume":"72","author":"Reeves","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1905","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2004.00966.x","article-title":"Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to l-dopa therapy","volume":"12","author":"Rektorova","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1468-1331.2003.00612.x","article-title":"Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study","volume":"10","author":"Rektorov\u00e1","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1920","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/srep02053","article-title":"VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival","volume":"3","author":"Religa","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1925","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1930","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1281","article-title":"Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice","author":"Renoir","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1935","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2012.239798","article-title":"Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice","volume":"591","author":"Renoir","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1940","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise","volume":"165","author":"Renoir","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1950","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1955","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","article-title":"Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography","volume":"1370","author":"Richards","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1960","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jsams.2015.01.005","article-title":"Enhanced exercise therapy in Parkinson's disease: a comparative effectiveness trial","volume":"19","author":"Ridgel","year":"2016","journal-title":"J. Sci. Med. Sport"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1965","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","article-title":"Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease","volume":"257","author":"Riedel","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1970","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/mp.2012.21","article-title":"A mega-analysis of genome-wide association studies for major depressive disorder","volume":"18","author":"Ripke","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1975","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Rodrigues","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1980","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002935","article-title":"Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's Ddisease","volume":"3","author":"Rodr\u00edguez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1985","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1353-8020(03)00067-1","article-title":"Depression in Parkinson's disease: clinical correlates and outcome","volume":"10","author":"Rojo","year":"2003","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1990","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1532-5415.2007.01035.x","article-title":"Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial","volume":"55","author":"Rolland","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib1995","first-page":"1","article-title":"Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease","volume":"18","author":"Romano","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2000","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pnpbp.2018.05.001","article-title":"Antidepressant effects of creatine on amyloid \u03b21-40-treated mice: the role of GSK-3\u03b2\/Nrf2 pathway","volume":"86","author":"Rosa","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.10.003","article-title":"Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice","volume":"127","author":"Rosa","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2010","doi-asserted-by":"crossref","DOI":"10.1001\/jama.292.12.1431-b","article-title":"Age-related testosterone depletion and the development of Alzheimer disease","author":"Rosario","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","article-title":"Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?","volume":"43","author":"Rosenberg","year":"2015","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0033-3182(00)71170-4","article-title":"Neuropsychiatry of Huntington's disease and other basal ganglia disorders","volume":"41","author":"Rosenblatt","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jpsychires.2011.01.013","article-title":"Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder","volume":"45","author":"Roth","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2035","volume":"4","author":"Rovio","year":"2005","journal-title":"Leisure-time physical activity at midlife and the risk of dementia and Alzheimer\u2019 s disease"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12877-016-0281-7","article-title":"Potential neuroimaging biomarkers of pathologic brain changes in mild cognitive impairment and Alzheimer's disease: a systematic review","volume":"16","author":"Ruan","year":"2016","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies","volume":"12","author":"Ruh\u00e9","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jagp.2015.03.006","article-title":"Chronic depressive symptomatology in mild cognitive impairment is associated with frontal atrophy rate which hastens conversion to Alzheimer dementia","volume":"24","author":"Sacuiu","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.parkreldis.2014.03.020","article-title":"Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease","volume":"20","author":"Sagna","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2060","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nn1969","article-title":"Adult hippocampal neurogenesis in depression","volume":"10","author":"Sahay","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuroscience.2006.08.069","article-title":"Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat","volume":"144","author":"Sairanen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.54.1.119","article-title":"Bradykinesia in early Huntington's disease","volume":"54","author":"Sanchez-Pernaute","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2080","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"S\u00e1nchez","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2085","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbr.2013.10.035","article-title":"Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin","volume":"259","author":"Santiago","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2015.05.030","article-title":"The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease","volume":"300","author":"Santiago","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2015.11.011","article-title":"Microglial dysfunction connects depression and Alzheimer's disease","volume":"55","author":"Santos","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2110","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.108.049619","article-title":"Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population","volume":"194","author":"Savva","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0149-7634(99)00059-7","article-title":"Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons","author":"Sawada","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000323779","article-title":"Serum levels of chemokines in Parkinson's disease","volume":"18","author":"Scalzo","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.expneurol.2004.11.016","article-title":"Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats","volume":"192","author":"Scharfman","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2522\/ptj.20110472","article-title":"Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial","volume":"92","author":"Schenkman","year":"2012","journal-title":"Phys. Ther."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2135","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-2236(00)01672-6","article-title":"The neurotrophin hypothesis for synaptic plasticity","author":"Schinder","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA major depressive disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2011.08.001","article-title":"Biomarkers for major depression and its delineation from neurodegenerative disorders","author":"Schneider","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2150","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv055","article-title":"New criteria for Alzheimer's disease: which, when and why?","volume":"138","author":"Schott","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2165","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/hmg\/ddn211","article-title":"Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II\/III in YAC72 and R6\/2 transgenic mice partially model Huntington's disease patients","volume":"17","author":"Seo","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2170","doi-asserted-by":"crossref","DOI":"10.1177\/104012371502700308","article-title":"NMDA receptor antagonists for depression: critical considerations","author":"Serafini","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2175","first-page":"1010","article-title":"A comparison between low doses of amitriptyline and low doses of fluoxetin used in the control of depression in patients suffering from Parkinson's disease","volume":"35","author":"Serrano-Due\u00f1as","year":"2002","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2185","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archgenpsychiatry.2011.1862","article-title":"Magnetic resonance imaging in late-life depression: multimodal examination of network disruption","volume":"69","author":"Sexton","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000161058","article-title":"Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia","volume":"26","author":"Sharp","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2200","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0006-3223(00)00994-X","article-title":"3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity","author":"Sheline","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2205","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/WNL.0b013e3182a956ad","article-title":"Risk of Parkinson disease after depression: a nationwide population-based study","volume":"81","author":"Shen","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2210","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington's disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-148010","article-title":"A review of pharmacological treatments for depression in Alzheimer's disease","volume":"48","author":"Siarkos","year":"2015","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neurobiolaging.2012.05.012","article-title":"Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe\/PS1dE9 mice","volume":"34","author":"Sierksma","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2230","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer's disease","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2235","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2240","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2245","doi-asserted-by":"crossref","DOI":"10.1159\/000318842","article-title":"Impact of gender differences on the outcome of alzheimer's disease","author":"Sinforiani","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2250","volume":"vol. 302","author":"Singleton","year":"2003"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2255","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1017\/S0007114511004788","article-title":"Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial","volume":"107","author":"Sinn","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S109285290002201X","article-title":"Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment","volume":"6","author":"Slaughter","year":"2001","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/jnp.13.2.187","article-title":"Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease","volume":"13","author":"Slaughter","year":"2001","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2270","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2275","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2280","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2015.12.003","article-title":"The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: acting separately or synergistically?","author":"Song","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2285","doi-asserted-by":"crossref","DOI":"10.1038\/srep28322","article-title":"Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease","volume":"6","author":"Soylu-Kucharz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0166-2236(81)90037-0","article-title":"The neurochemistry of Huntington's chorea","volume":"4","author":"Spokes","year":"1981","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2295","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1017\/S003329171300247X","article-title":"The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study","volume":"44","author":"Sprengelmeyer","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2300","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","article-title":"The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease","volume":"31","author":"Spuch","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jnnp.53.7.597","article-title":"Cognitive impairments and depression in Parkinson's disease: a follow up study","volume":"53","author":"Starkstein","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp.55.5.377","article-title":"A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease","volume":"55","author":"Starkstein","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mds.870130109","article-title":"Depression in classic versus akinetic-rigid Parkinson's disease","volume":"13","author":"Starkstein","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2325","doi-asserted-by":"crossref","DOI":"10.2165\/00023210-199809030-00001","article-title":"Delayed onset of action of antidepressants: fact or fiction?","author":"Stassen","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2330","series-title":"The 10 Leading Causes of Death, 2011","author":"Statistics Canada","year":"2015"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.05.004","article-title":"Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington's disease","volume":"105","author":"Stefanko","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2340","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1017\/S1041610215002069","article-title":"Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients","volume":"28","author":"Stella","year":"2016","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(93)90073-Q","article-title":"Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington's disease","volume":"242","author":"Steward","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2350","first-page":"435","article-title":"5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment","volume":"25","author":"Stuerenburg","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2355","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01376517-200106000-00005","article-title":"Remotivation therapy and Huntington's disease","volume":"33","author":"Sullivan","year":"2001","journal-title":"J. Neurosci. Nurs."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2360","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease?","volume":"65","author":"Sun","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2012.08.065","article-title":"Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity","author":"Suri","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2370","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2375","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neubiorev.2013.03.018","article-title":"Potential roles of zinc in the pathophysiology and treatment of major depressive disorder","volume":"37","author":"Swardfager","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2380","doi-asserted-by":"crossref","DOI":"10.1016\/S1734-1140(13)71523-8","article-title":"Possible contribution of IGF-1 to depressive disorder","author":"Szcz\u00easny","year":"2013","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuropharm.2015.09.003","article-title":"Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine","volume":"101","author":"Szot","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2390","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2395","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtemb.2012.03.016","article-title":"Zinc signaling in the hippocampus and its relation to pathogenesis of depression","volume":"26","author":"Takeda","year":"2012","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2405","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2410","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF03006670","article-title":"Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease","volume":"17","author":"Tanaka","year":"2003","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2415","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2420","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.neurobiolaging.2012.10.029","article-title":"Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease","volume":"34","author":"Tang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2425","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","article-title":"Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia","volume":"23","author":"Tarkowski","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2430","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2435","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.290.15.2015","article-title":"Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial","volume":"290","author":"Teri","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2440","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease","volume":"18","author":"The National Institute of Aging, and Reagan Institute working group on the diagnostic criteria for the neuropathological assessment of Alzheimer\u2019s disease","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2445","doi-asserted-by":"crossref","DOI":"10.1002\/hup.386","article-title":"Onset of action of antidepressants: results of different analyses","volume":"17","author":"Thompson","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2450","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neubiorev.2019.04.002_bib2455","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/brain\/111.2.223","article-title":"The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement","volume":"111","author":"Thompson","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2460","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674370705200407","article-title":"Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis","volume":"52","author":"Thompson","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2465","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.38313.513310.F71","article-title":"Insulin resistance and depression: cross sectional study","volume":"330","author":"Timonen","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care","author":"Trillo","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2475","doi-asserted-by":"crossref","first-page":"e79510","DOI":"10.1371\/journal.pone.0079510","article-title":"A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease","volume":"8","author":"Troeung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4306\/pi.2010.7.4.236","article-title":"Effects of bdnf polymorphisms on antidepressant action","volume":"7","author":"Tsai","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2485","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.bp.110.078816","article-title":"Neuropathological correlates of late-life depression in older people","volume":"198","author":"Tsopelas","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2490","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainresbull.2014.09.006","article-title":"Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease","volume":"108","author":"Tuon","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2495","first-page":"241","volume":"vol. 38","author":"Ugrumov","year":"2009"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2500","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2505","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2510","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1191\/0269215504cr750oa","article-title":"Cognitive and behavioural effects of music-based exercises in patients with dementia","volume":"18","author":"Van de Winckel","year":"2004","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2515","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2520","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4088\/JCP.v69n1116","article-title":"Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives","volume":"69","author":"van Duijn","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2525","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington's disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2530","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainresbull.2010.08.006","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls","volume":"83","author":"van Duijn","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2535","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jnr.490210113","article-title":"Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus","volume":"21","author":"Van Eekelen","year":"1988","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2540","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mds.26112","article-title":"Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume","volume":"30","author":"van Mierlo","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2545","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1073\/pnas.96.23.13427","article-title":"Running enhances neurogenesis, learning, and long-term potentiation in mice","volume":"96","author":"van Praag","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2550","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2555","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jne.12190","article-title":"Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models","author":"van Wamelen","year":"2014","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2560","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1460-9568.2004.03720.x","article-title":"Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition","volume":"20","author":"Vaynman","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2565","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2570","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopsych.2017.10.023","article-title":"(\u2013)-P7C3-S243 protects a rat model of Alzheimer's disease from neuropsychiatric deficits and neurodegeneration without altering amyloid deposition or reactive glia","volume":"84","author":"Voorhees","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2575","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2580","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(89)90082-1","article-title":"Serotonin-1 receptor binding sites in the human basal ganglia are decreased in huntington's chorea but not in parkinson's disease: a quantitative in vitro autoradiography study","volume":"32","author":"Waeber","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2585","first-page":"1967","article-title":"Depression during L-DOPA treatment","volume":"294","author":"Wagshul","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2590","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2595","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1142\/S021963521650014X","article-title":"Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer's disease associated mice","volume":"15","author":"Wang","year":"2016","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2600","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopha.2016.11.111","article-title":"Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington's disease-like symptoms in mice","volume":"86","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2605","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroimage.2005.12.033","article-title":"Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI","volume":"31","author":"Wang","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2610","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbrc.2011.07.003","article-title":"VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease","volume":"411","author":"Wang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2615","first-page":"3853","article-title":"Relationship between levels of inflammatory cytokines in the peripheral blood and the severity of depression and anxiety in patients with Parkinson's disease","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.05.012","article-title":"Association of low serum BDNF with depression in patients with Parkinson's disease","volume":"41","author":"Wang","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2625","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1073\/pnas.0610282104","article-title":"VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants","volume":"104","author":"Warner-Schmidt","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2630","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2635","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","article-title":"Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease","volume":"75","author":"Weintraub","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2640","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","article-title":"Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes","volume":"18","author":"Weintraub","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2645","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ene.13002","article-title":"Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies","volume":"23","author":"Wen","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2650","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.191352298","article-title":"Calcium regulation of neuronal gene expression","volume":"98","author":"West","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2655","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2660","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jagp.2014.05.001","article-title":"Depression and Synaptic zinc regulation in alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia","volume":"23","author":"Whitfield","year":"2015","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2665","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awm112","article-title":"3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2670","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2015.05.067","article-title":"Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk","volume":"184","author":"Wiener","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2675","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13607860701529932","article-title":"Exercise training for depressed older adults with Alzheimer's disease","volume":"12","author":"Williams","year":"2008","journal-title":"Aging Ment. Health"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2680","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","author":"Willner","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2685","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2690","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2695","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/jnnp.53.10.915","article-title":"Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease","volume":"53","author":"Wolfe","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2700","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-4328(96)00106-4","article-title":"Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders","volume":"73","author":"Wong","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2705","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BPL-150019","article-title":"FNDC5\/irisin \u2013 their role in the nervous system and as a mediator for beneficial effects of exercise on the brain Christiane","volume":"1","author":"Wrann","year":"2015","journal-title":"Brain Plast."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2710","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","article-title":"Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway","volume":"18","author":"Wrann","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2715","first-page":"2923","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease","volume":"25","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2720","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/jnp.23.1.jnp63","article-title":"SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease","volume":"23","author":"Wu","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2725","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2010.04.005","article-title":"The putative neurodegenerative links between depression and Alzheimer's disease","author":"Wuwongse","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nm0498-447","article-title":"Estrogen reduces neuronal generation of Alzheimer \u03b2-amyloid peptides","volume":"4","author":"Xu","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2735","series-title":"Treatment of Parkinsonism With Levodopa","author":"Yahr","year":"1833"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2740","doi-asserted-by":"crossref","DOI":"10.1007\/PL00022917","article-title":"Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background","author":"Yamamoto","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2745","series-title":"Effects of Pramipexole on Depression in Parkinson's Disease: A Systematic Review. Progress in Modern Biomedicine. Editorial Board of Progress in Modern Biomedicine","author":"YanChang","year":"2010"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2750","doi-asserted-by":"crossref","first-page":"403120","DOI":"10.1155\/2014\/403120","article-title":"Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases?","volume":"2014","author":"Yau","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2755","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.1073\/pnas.1415219111","article-title":"Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin","volume":"111","author":"Yau","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2760","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molbrainres.2003.08.009","article-title":"Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology","volume":"119","author":"Yohrling","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2765","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2009.94","article-title":"Sex, trauma, stress hormones and depression","author":"Young","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2770","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2010.184","article-title":"The role of BDNF in depression on the basis of its location in the neural circuitry","author":"Yu","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2775","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jagp.2013.01.043","article-title":"Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment?. for the Alzheimer's disease neuroimaging initiative","volume":"21","author":"Zahodne","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2780","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hipo.20658","article-title":"Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice","volume":"20","author":"Zajac","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2785","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12640-014-9467-y","article-title":"Antidepressant and antioxidative effect of ibuprofen in the rotenone model of Parkinson's disease","volume":"26","author":"Zaminelli","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2790","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2012.01.015","article-title":"An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease","volume":"229","author":"Zarringhalam","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2795","article-title":"Donepezil: a review of pharmacological characteristics and role in the management of Alzheimer disease","volume":"10","author":"Zeb","year":"2017","journal-title":"Clin. Med. Insights Geriatr."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2800","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11011-013-9424-0","article-title":"The preventive effect of NR2B and NR2D-containing NMDAR antagonists on A\u03b2-induced LTP disruption in the dentate gyrus of rats","volume":"28","author":"Zhang","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2805","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JAD-2011-110113","article-title":"BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response","volume":"26","author":"Zhang","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2810","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuropharm.2017.12.021","article-title":"Citalopram restores short-term memory deficit and non-cognitive behaviors in APP\/PS1 mice while halting the advance of Alzheimer's disease-like pathology","volume":"131","author":"Zhang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2815","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2015.10.016","article-title":"Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease rat model","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2820","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00101","article-title":"MPTP impairs dopamine D1 receptor-mediated survival of newborn neurons in ventral hippocampus to cause depressive-like behaviors in adult mice","volume":"9","author":"Zhang","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2825","article-title":"Dysfunction of NMDA receptors in Alzheimer's disease","author":"Zhang","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2016.07.014","article-title":"Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson's rats","volume":"110","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2835","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2016.02.011","article-title":"Sex differences in metabolic aging of the brain: Insights into female susceptibility to Alzheimer's disease","volume":"42","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2840","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2845","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ijo.2009.65","article-title":"Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals","volume":"33","author":"Zheng","year":"2009","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2850","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2855","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/mcne.1998.0684","article-title":"Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb","volume":"11","author":"Zigova","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2860","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2865","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neubiorev.2019.04.002_bib2870","doi-asserted-by":"crossref","first-page":"681","DOI":"10.12659\/MSM.889110","article-title":"Plasma cortisol in Alzheimer's disease with or without depressive symptoms","volume":"19","author":"Zv\u011b\u0159ov\u00e1","year":"2013","journal-title":"Med. Sci. Monit."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418309126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418309126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:29:21Z","timestamp":1758965361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763418309126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":574,"alternative-id":["S0149763418309126"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.002","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression in neurodegenerative diseases: Common mechanisms and current treatment options","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}